Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients

Autor: François Lang, Sylvain Simon, Agnès Fortun, Amir Khammari, Virginie Vignard, Brigitte Dréno, Nicolas Jouand, Soraya Saiagh, Nathalie Labarrière, Tiffany Beauvais, Sylvain Bercegay

Publikováno v: Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy, Springer Verlag, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩
Cancer Immunology, Immunotherapy, 2021, Online ahead of print. ⟨10.1007/s00262-021-02961-0⟩

Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells should combine tumor specificity and reactivity with survival in vivo, while avoiding autoimm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb8593ae7b130854c47879fa356985a5
https://www.hal.inserm.fr/inserm-03260784/document